Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Hypoxia inducible factor-1alpha is a prognostic marker in premenopausal patients with intermediate to highly differentiated breast cancer but not a predictive marker for tamoxifen response.
Int J Cancer. 2006 May 15;118(10):2609-16. doi: 10.1002/ijc.21676.
Int J Cancer. 2006.
PMID: 16381002
Free article.
Cyclin D1 overexpression is a negative predictive factor for tamoxifen response in postmenopausal breast cancer patients.
Stendahl M, Kronblad A, Rydén L, Emdin S, Bengtsson NO, Landberg G.
Stendahl M, et al. Among authors: kronblad a.
Br J Cancer. 2004 May 17;90(10):1942-8. doi: 10.1038/sj.bjc.6601831.
Br J Cancer. 2004.
PMID: 15138475
Free PMC article.
Clinical Trial.
Item in Clipboard
Hypoxia promotes a dedifferentiated phenotype in ductal breast carcinoma in situ.
Helczynska K, Kronblad A, Jögi A, Nilsson E, Beckman S, Landberg G, Påhlman S.
Helczynska K, et al. Among authors: kronblad a.
Cancer Res. 2003 Apr 1;63(7):1441-4.
Cancer Res. 2003.
PMID: 12670886
Item in Clipboard
Adverse effect of adjuvant tamoxifen in premenopausal breast cancer with cyclin D1 gene amplification.
Jirström K, Stendahl M, Rydén L, Kronblad A, Bendahl PO, Stål O, Landberg G.
Jirström K, et al. Among authors: kronblad a.
Cancer Res. 2005 Sep 1;65(17):8009-16. doi: 10.1158/0008-5472.CAN-05-0746.
Cancer Res. 2005.
PMID: 16140974
Clinical Trial.
Item in Clipboard
CA IX is an independent prognostic marker in premenopausal breast cancer patients with one to three positive lymph nodes and a putative marker of radiation resistance.
Brennan DJ, Jirstrom K, Kronblad A, Millikan RC, Landberg G, Duffy MJ, Rydén L, Gallagher WM, O'Brien SL.
Brennan DJ, et al. Among authors: kronblad a.
Clin Cancer Res. 2006 Nov 1;12(21):6421-31. doi: 10.1158/1078-0432.CCR-06-0480.
Clin Cancer Res. 2006.
PMID: 17085655
Clinical Trial.
Item in Clipboard
Regional cyclin D1 overexpression or hypoxia correlate inversely with heterogeneous oestrogen receptor-alpha expression in human breast cancer.
Kronblad A, Helczynska K, Nielsen NH, Påhlman E, Emdin S, Påhlman S, Landberg G.
Kronblad A, et al.
In Vivo. 2003 Jul-Aug;17(4):311-8.
In Vivo. 2003.
PMID: 12929585
Item in Clipboard
ERK1/2 inhibition increases antiestrogen treatment efficacy by interfering with hypoxia-induced downregulation of ERalpha: a combination therapy potentially targeting hypoxic and dormant tumor cells.
Kronblad A, Hedenfalk I, Nilsson E, Påhlman S, Landberg G.
Kronblad A, et al.
Oncogene. 2005 Oct 13;24(45):6835-41. doi: 10.1038/sj.onc.1208830.
Oncogene. 2005.
PMID: 16007158
Item in Clipboard
Cite
Cite